This article has been cited by
1Network meta-analysis of lorcaserin and oral hypoglycaemics for patients with type 2 diabetes mellitus and obesity
L. M. Neff,M. S. Broder,D. Beenhouwer,E. Chang,E. Papoyan,Z. W. Wang
Clinical Obesity.2017;7(6)337
[DOI]
2Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis
Elizabeth S. Mearns,Diana M. Sobieraj,C. Michael White,Whitney J. Saulsberry,Christine G. Kohn,Yunes Doleh,Eric Zaccaro,Craig I. Coleman,Wen-Chih Hank Wu
PLOS ONE.2015;10(4)e0125879
[DOI]
3Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report
SarayuA Pai,NilimaA Kshirsagar
Indian Journal of Medical Research.2016;144(5)672
[DOI]
4Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
Elena Pavlova Filipova,Katya Hristova Uzunova,Toni Yonkov Vekov
Diabetology & Metabolic Syndrome.2015;7(1)672
[DOI]
5Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24?weeks
Sin Gon Kim,Kyoung Jin Kim,Kun Ho Yoon,Sung Wan Chun,Kyong Soo Park,Kyung Mook Choi,Soo Lim,Ji-Oh Mok,Hyoung Woo Lee,Ji A. Seo,Bong-Soo Cha,Mi Kyung Kim,Ho Sang Shon,Dong Seop Choi,Doo Man Kim
Diabetes, Obesity and Metabolism.2020;22(10)1869
[DOI]
6Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study
M. Bajaj,R. Gilman,S. Patel,J. Kempthorne-Rawson,D. Lewis-D'Agostino,H.-J. Woerle
Diabetic Medicine.2014;31(12)1505
[DOI]
7The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients
Nasser Aghamohammadzadeh,Mitra Niafar,Elham Dalir Abdolahinia,Farzad Najafipour,Saeed Mohamadzadeh Gharebaghi,Khadijeh Adabi,Elaheh Dalir Abdolahinia,Hamidreza Ahadi
Therapeutic Advances in Endocrinology and Metabolism.2015;6(2)56
[DOI]
8Enhancement of cognitive functions by rice bran extract in a neuroinflammatory mouse model via regulation of PPAR?
A.O. Mostafa,R.M. Abdel-Kader,O.A. Heikal
Journal of Functional Foods.2018;48(2)314
[DOI]
9Topical Retinoids in Acne Vulgaris: A Systematic Review
Sree S. Kolli,Danielle Pecone,Adrian Pona,Abigail Cline,Steven R. Feldman
American Journal of Clinical Dermatology.2019;20(3)345
[DOI]
10Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Surjit Singh,Anil Bhansali
BMC Dermatology.2016;16(1)345
[DOI]
11Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and -Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis
Jaehyun Bae,Gyuri Kim,Yong-Ho Lee,Byung-Wan Lee,Eun Seok Kang,Bong-Soo Cha
Diabetes Therapy.2019;10(1)149
[DOI]
12The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy
Mariann Bombicz,Daniel Priksz,Rudolf Gesztelyi,Rita Kiss,Nora Hollos,Balazs Varga,Jozsef Nemeth,Attila Toth,Zoltan Papp,Zoltan Szilvassy,Bela Juhasz
Molecules.2019;24(3)586
[DOI]
13Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis
Elena Filipova,Katya Uzunova,Krassimir Kalinov,Toni Vekov
Diabetology & Metabolic Syndrome.2017;9(1)586
[DOI]
14A PROSPECTIVE STUDY OF ADDITION OF SITAGLIPTIN TO METFORMIN VERSUS METFORMIN ALONE IN TYPE 2 DIABETES MELLITUS PATIENTS
Ramswaroop Jawaharlal,Pravin G. Maske
Journal of Evidence Based Medicine and Healthcare.2017;4(73)4327
[DOI]
  Feedback 
  Subscribe